![conference banner](/images/conference-banner.jpeg)
Abstract
The biological bases of cellular and organismal aging are thought to involve, among others, basic stress response mechanisms. In this field an increasing amount of evidence, in recent years, point towards an important role of endogenous retroelements. During evolution these mobile genetic elements interpreted the dual role of selfish genomic parasites and useful “boosters” of genomic evolution. Similarly, in living cell these elements have an important role in stress response and in generating neuronal plasticity, but studies on in vitro cell cultures and animal models show that their excessive activation or misregulation may lead to DNA damage and cell senescence, and can trigger both innate immunity and a pro-inflammatory response. Being cell senescence, somatic DNA damage and inflammation three supposed key processes in human aging, and observing that several intracellular mechanisms normally controlling the activation of retroelements show a tendency to fade at late ages, a possible role of endogenous retroelements in organismal senescence is taken in consideration. A better knowledge of the basic mechanisms linking stress response, activation of endogenous retroelements and age-related cell/tissue alterations could not only help us gain a better understanding of the basic mechanisms of aging, but will also allow the experimentation of new therapeutic targets for different age-related diseases.
Keywords: Aging, senescence, stress, retrotransposon, retroelement, antagonistic pleiotropy, hormesis, innate immunity, DNA damage, inflammation
Current Pharmaceutical Design
Title:Good, Bad, Mobile Elements: Genome’s Most Successful “Parasites” as Emerging Players in Cell and Organismal Aging
Volume: 19 Issue: 9
Author(s): Maurizio Cardelli and Francesca Marchegiani
Affiliation:
Keywords: Aging, senescence, stress, retrotransposon, retroelement, antagonistic pleiotropy, hormesis, innate immunity, DNA damage, inflammation
Abstract: The biological bases of cellular and organismal aging are thought to involve, among others, basic stress response mechanisms. In this field an increasing amount of evidence, in recent years, point towards an important role of endogenous retroelements. During evolution these mobile genetic elements interpreted the dual role of selfish genomic parasites and useful “boosters” of genomic evolution. Similarly, in living cell these elements have an important role in stress response and in generating neuronal plasticity, but studies on in vitro cell cultures and animal models show that their excessive activation or misregulation may lead to DNA damage and cell senescence, and can trigger both innate immunity and a pro-inflammatory response. Being cell senescence, somatic DNA damage and inflammation three supposed key processes in human aging, and observing that several intracellular mechanisms normally controlling the activation of retroelements show a tendency to fade at late ages, a possible role of endogenous retroelements in organismal senescence is taken in consideration. A better knowledge of the basic mechanisms linking stress response, activation of endogenous retroelements and age-related cell/tissue alterations could not only help us gain a better understanding of the basic mechanisms of aging, but will also allow the experimentation of new therapeutic targets for different age-related diseases.
Export Options
About this article
Cite this article as:
Cardelli Maurizio and Marchegiani Francesca, Good, Bad, Mobile Elements: Genome’s Most Successful “Parasites” as Emerging Players in Cell and Organismal Aging, Current Pharmaceutical Design 2013; 19 (9) . https://dx.doi.org/10.2174/1381612811319090021
DOI https://dx.doi.org/10.2174/1381612811319090021 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dissecting the Therapeutic Relevance of Gene Therapy in NeuroAIDS: An Evolving Epidemic
Current Gene Therapy TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
Current Drug Targets Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?
Current Neuropharmacology Biophysical Characterization of the Nucleoside Diphosphate Kinase of Leishmania major and Effect of the P95S Mutation
Protein & Peptide Letters Multifunctional Role of Pacap-Like Peptides in Molluscs
Protein & Peptide Letters Endocytosis, Intracellular Traffic and Fate of Cell Penetrating Peptide Based Conjugates and Nanoparticles
Current Pharmaceutical Design Nutritional Aspects Relating to the Developmental Origins of Health and Disease
Current Women`s Health Reviews The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours
Recent Patents on CNS Drug Discovery (Discontinued) Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry Nutraceuticals as Potential Chemopreventive Agents: A Review
The Natural Products Journal The Impact of Small Heat Shock Proteins (HspBs) in Alzheimer’s and Other Neurological Diseases
Current Pharmaceutical Design Multifunctional Ligands with Glycogen Synthase Kinase 3 Inhibitory Activity as a New Direction in Drug Research for Alzheimer’s Disease
Current Medicinal Chemistry Control of β-Site Amyloid Precursor Protein-Cleaving Enzyme-1 Expression by Protein Kinase C-λ/ι and Nuclear Factor κ-B
Current Alzheimer Research Naphthoflavones as Antiproliferative Agents: Design, Synthesis and Biological Evaluation
Anti-Cancer Agents in Medicinal Chemistry Highly Organized Nanostructures for Brain Drug Delivery - New Hope or Just a Fad?
CNS & Neurological Disorders - Drug Targets Genetic and Modifying Factors that Determine the Risk of Brain Tumors
Central Nervous System Agents in Medicinal Chemistry A Cationic Gallium Phthalocyanine Inhibits Amyloid β Peptide Fibril Formation
Current Alzheimer Research Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses
Current Pharmaceutical Biotechnology DNA Intercalators in Cancer Therapy: Organic and Inorganic Drugs and Their Spectroscopic Tools of Analysis
Mini-Reviews in Medicinal Chemistry Perspectives of Protein Kinase C (PKC) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry